More Parents Citing Safety as Reason for HPV Vaccine Hesitancy
23 May 2023
VaccineClinical Result
TUESDAY, May 23, 2023 -- The proportion of parents citing "safety or side effects" as a reason for human papillomavirus (HPV) vaccine hesitancy for their adolescent children increased from 2010 to 2018, according to a study published online May 23 in Pediatrics.
Eric Adjei Boakye, Ph.D., from the Henry Ford Health System in Detroit, and colleagues analyzed data from 119,695 adolescents aged 13 to 17 years from the 2010 to 2020 National Immunization Survey-Teen to examine reasons for HPV vaccination hesitancy.
The researchers found that "not necessary," "safety concerns," "lack of recommendation," "lack of knowledge," and "not sexually active" were the most frequently cited reasons for not intending to vaccinate. From 2010 to 2012, there was a 5.5 percent annual decrease observed in parental HPV vaccine hesitancy, which then remained stable from 2012 through 2020. From 2010 to 2018, there was a significant 15.6 percent annual increase seen in the proportion of parents citing "safety or side effects" as a reason for vaccine hesitancy. Between 2013 and 2020, there were decreases of 6.8, 9.9, and 5.9 percent per year noted in the proportion of parents citing "not recommended," "lack of knowledge," or "child not sexually active," respectively. There were no significant changes seen in the proportion of parents citing "not necessary."
"Strategies to combat safety concerns and improve vaccine confidence are urgently warranted," the authors write. "These findings support local, state, and national efforts to inform parents of the benefits of HPV vaccination for cancer prevention and to develop and disseminate strategies for addressing parental concerns about HPV vaccination."
Abstract/Full Text (subscription or payment may be required)
Posted May 2023
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
-Indications
Targets
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.